Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Ac
RecruitingNCT06667180Phase: PHASE1, PHASE2Started 2024-10-28
Summary
The goal of this randomised clinical trial is to evaluate the effects of transcranial magnetic stimulation (TMS) on major depressive disorder (MDD) and on the levels of 5-hydroxyindoleacetic acid (5-H
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
60 Years
Locations
High Specialty Medical Unit No. 1, Bajío. Mexican Social SecLeón, Guanajuato, Mexico
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06667180